Related Experiment Video
Updated: Sep 23, 2025
08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
9.5K
Mechanical Circulatory Support Options in Patients With Aortic Valve Pathology
Jeans Miguel Santana1, Adam A Dalia2, Melinda Newton3
1Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, MA.
Journal of Cardiothoracic and Vascular Anesthesia
|May 11, 2022
Summary
Mechanical circulatory support (MCS) offers hemodynamic stability for high-risk patients. This review details MCS options and considerations for aortic valve pathologies, aiding complex treatment decisions.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- Mechanical circulatory support (MCS) is crucial for managing cardiogenic shock and severe coronary artery disease.
- It provides hemodynamic stability, augments blood flow, and can assist with oxygenation and ventilation.
- MCS is typically employed when less invasive methods fail or are not tolerated, such as with significant ventricular arrhythmias.
Purpose of the Study:
- To review current Mechanical Circulatory Support (MCS) options.
- To highlight special considerations for selecting MCS in patients with aortic valve (AV) abnormalities.
- To aid complex decision-making in MCS selection.
Main Methods:
- Narrative review of existing literature on MCS.
- Analysis of different MCS devices including intra-aortic balloon pump, percutaneous ventricular assist devices, and extracorporeal membrane oxygenation.
- Examination of specific challenges posed by aortic valve pathologies.
Main Results:
- The increasing number of MCS options complicates treatment selection.
- Aortic valve abnormalities (stenosis, insufficiency, masses, or replacements) add significant complexity to MCS decision-making.
- Appropriate MCS selection requires careful consideration of patient hemodynamics and AV status.
Conclusions:
- Selecting the optimal MCS strategy is challenging, particularly with concurrent aortic valve disease.
- A comprehensive understanding of both MCS devices and AV pathology is essential for effective patient management.
- Further research may be needed to refine guidelines for MCS use in complex cardiac conditions.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
56
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
56
01:17Aortic Regurgitation IV: Nursing Management
67
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
67
01:22Heart Failure VI: Adjunct Therapies
42
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
42
01:26Mitral Stenosis III: Medical Management
31
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31
01:29Cardiomyopathy V: Interprofessional Care
47
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
47
01:30Cardiomyopathy II: Dilated Cardiomyopathy
36
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
36